In the past few days, there have been distress messages from people asking or medicines used in COVID treatment. To ensure that people do not have to go out of hospital pharmacies to procure these medicines, Telangana Drug Control Administration (DCA) officials checked supply, availability and consumption of Remdesivir and Tocilizumab in corporate hospitals in Hyderabad on Monday.
Officials also looked into the sale of the medicines in black market.
Names of hospitals which are supplied the drugs by depots were listed . DCA director Dr Preeti Meena said that separate teams of drug inspectors were formed who simultaneously visited corporate hospitals and depots which supply the medicines. They noted down the current availability of the medicines how the drugs are supplied from manufacturer to hospitals.
The drug inspectors checked registers of hospitals to know the amount of medicines supplied. Dr Meena said that their teams cross- checked the patient details to find out the vials consumed.
DCA Joint Director Y Navin Kumar said that while scarcity of Remdesivir will be resolved in one to two days, it will take a week to ten days to address shortage of Tocilizumab.
You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in
Show Less Plan
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Faster pages
Move smoothly between articles as our pages load instantly.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Personalised recommendations
A select list of articles that match your interests and tastes.
Briefing
We brief you on the latest and most important developments, three times a day.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath